Cargando…
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome
Angelman syndrome (AS) is a rare (~1:15,000) neurodevelopmental disorder characterized by severe developmental delay and intellectual disability, impaired communication skills, and a high prevalence of seizures, sleep disturbances, ataxia, motor deficits, and microcephaly. AS is caused by loss-of-fu...
Autores principales: | Copping, Nycole A., McTighe, Stephanie M., Fink, Kyle D., Silverman, Jill L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608975/ https://www.ncbi.nlm.nih.gov/pubmed/34528170 http://dx.doi.org/10.1007/s13311-021-01082-x |
Ejemplares similares
-
Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells
por: Adhikari, Anna, et al.
Publicado: (2021) -
Unique Features of the Gut Microbiome Characterized in Animal Models of Angelman Syndrome
por: Beitnere, Ulrika, et al.
Publicado: (2023) -
Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome
por: Copping, N. A., et al.
Publicado: (2021) -
Neurodevelopmental Underpinnings of Angelman Syndrome
por: Li, Guohui, et al.
Publicado: (2014) -
Angelman syndrome: advancing the research frontier of neurodevelopmental disorders
por: Philpot, Benjamin D., et al.
Publicado: (2010)